Deborah Keller, an experienced life sciences executive, has been appointed chair of the board of trustees for the Wisconsin Alumni Research Foundation (WARF), the patent and licensing arm of the University of Wisconsin-Madison.
Keller succeeds Dr. Jim Berbee, a clinical assistant professor at the University of Wisconsin School of Medicine and Public Health in Madison, who was appointed board chair in 2018, WARF said in a press release.
Keller served nearly 30 years at Covance Inc., the drug development business of Burlington, North Carolina-based Laboratory Corp. of America (NYSE: LH), which has a laboratory in Madison. She retired from Covance in 2016 when she was CEO of the Covance Drug Development division.
At Covance, Keller was responsible for $3 billion in revenue and more than 12,000 employees in 125 countries involved in all phases of drug development from late discovery to commercialization services to pharmaceutical and biotechnology companies, WARF said.
“Her leadership is evident in all her contributions to WARF and UW and her expertise in drug development is an important complement to WARF and UW-Madison’s portfolio of work in this area,” said Erik Iverson, WARF CEO.
Learn more here: https://www.bizjournals.com/milwaukee/inno/stories/news/2024/06/12/warf-deborah-keller-chair-research-foundation.html